Crucial Role of Reactive Oxygen Species (ROS) for the Proapoptotic Effects of Indirubin Derivatives in Cutaneous SCC Cells
Abstract
:1. Introduction
2. Materials and Methods
2.1. Cell Culture and Treatment
2.2. Cell Proliferation Assays
2.3. Determination of Apoptosis, Cell Viability and Cytotoxicity
2.4. Mitochondrial Membrane Potential
2.5. Analysis of Reactive Oxygen Species (ROS)
2.6. Western Blotting
2.7. Statistical Analyses
3. Results
3.1. Decreased cSCC Cell Proliferation, Induction of Apoptosis and Loss of Cell Viability
3.2. Changes of Mitochondrial Membrane Potential
3.3. High ROS Production in Response to Indirubin Derivatives in cSCC Cells
3.4. Strong Caspase Activation in Course of Combined Treatment
3.5. Regulation of Characteristic Mediators of Apoptosis and Cell Proliferation
3.6. Function of Caspases
3.7. Critical Roles of ROS
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Alam, M.; Ratner, D. Cutaneous squamous-cell carcinoma. N. Engl. J. Med. 2001, 344, 975–983. [Google Scholar] [CrossRef] [PubMed]
- Szewczyk, M.; Pazdrowski, J.; Golusiński, P.; Dańczak-Pazdrowska, A.; Marszałek, S.; Golusiński, W. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 2015, 272, 3007–3012. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Amaral, T.; Osewold, M.; Presser, D.; Meiwes, A.; Garbe, C.; Leiter, U. Advanced cutaneous squamous cell carcinoma: Real world data of patient profiles and treatment patterns. J. Eur. Acad. Derm. Venereol. 2019, 33 (Suppl. S8), 44–51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agbai, O.N.; Buster, K.; Sanchez, M.; Hernandez, C.; Kundu, R.V.; Chiu, M.; Roberts, W.E.; Draelos, Z.D.; Bhushan, R.; Taylor, S.C.; et al. Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public. J. Am. Acad. Derm. 2014, 70, 748–762. [Google Scholar] [CrossRef]
- Halder, R.M.; Bridgeman-Shah, S. Skin cancer in African Americans. Cancer 1995, 75, 667–673. [Google Scholar] [CrossRef]
- Eberle, J. Countering TRAIL Resistance in Melanoma. Cancers 2019, 11, 656. [Google Scholar] [CrossRef] [Green Version]
- Hanahan, D.; Weinberg, R.A. Hallmarks of Cancer: The Next Generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [Green Version]
- Galluzzi, L.; Vitale, I.; Aaronson, S.A.; Abrams, J.M.; Adam, D.; Agostinis, P.; Alnemri, E.S.; Altucci, L.; Amelio, I.; Andrews, D.W.; et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018, 25, 486–541. [Google Scholar] [CrossRef]
- Chipuk, J.E.; Moldoveanu, T.; Llambi, F.; Parsons, M.J.; Green, D.R. The BCL-2 Family Reunion. Mol. Cell 2010, 37, 299–310. [Google Scholar] [CrossRef]
- Karimian, A.; Ahmadi, Y.; Yousefi, B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair 2016, 42, 63–71. [Google Scholar] [CrossRef]
- Krammer, P.H.; Arnold, R.; Lavrik, I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7, 532–542. [Google Scholar] [CrossRef]
- Ashkenazi, A.; Holland, P.; Eckhardt, S.G. Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J. Clin. Oncol. 2008, 26, 3621–3630. [Google Scholar] [CrossRef]
- Walczak, H.; Miller, R.E.; Ariail, K.; Gliniak, B.; Griffith, T.S.; Kubin, M.; Chin, W.; Jones, J.; Woodward, A.; Le, T.; et al. Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo. Nat. Med. 1999, 5, 157–163. [Google Scholar] [CrossRef]
- Hitomi, J.; Katayama, T.; Eguchi, Y.; Kudo, T.; Taniguchi, M.; Koyama, Y.; Manabe, T.; Yamagishi, S.; Bando, Y.; Imaizumi, K.; et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A beta-induced cell death. J. Cell Biol. 2004, 165, 347–356. [Google Scholar] [CrossRef]
- Martinon, F.; Tschopp, J. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ. 2007, 14, 10–22. [Google Scholar] [CrossRef]
- Fischer, U.; Janicke, R.U.; Schulze-Osthoff, K. Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ. 2003, 10, 76–100. [Google Scholar] [CrossRef]
- Yuan, Z.L.; Guan, Y.J.; Wang, L.; Wei, W.; Kane, A.B.; Chin, Y.E. Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol. Cell Biol. 2004, 24, 9390–9400. [Google Scholar] [CrossRef] [Green Version]
- Benhadji, K.A.; Serova, M.; Ghoul, A.; Cvitkovic, E.; Le Tourneau, C.; Ogbourne, S.M.; Lokiec, F.; Calvo, F.; Hammel, P.; Faivre, S.; et al. Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells. Brit. J. Cancer 2008, 99, 1808–1815. [Google Scholar] [CrossRef]
- Zhang, J.; Anastasiadis, P.Z.; Liu, Y.; Thompson, E.A.; Fields, A.P. Protein kinase C (PKC) beta II induces cell invasion through a Ras/Mek-, PKC iota/Rac1-dependent signaling pathway. J. Biol. Chem. 2004, 279, 22118–22123. [Google Scholar] [CrossRef] [Green Version]
- Zhao, M.; Xia, L.; Chen, G.Q. Protein Kinase C delta in Apoptosis: A Brief Overview. Arch. Immunol. Ex. 2012, 60, 361–372. [Google Scholar] [CrossRef]
- Kato, K.; Yamanouchi, D.; Esbona, K.; Kamiya, K.; Zhang, F.; Kent, K.C.; Liu, B. Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells. Am. J. Physiol. Heart C 2009, 297, H2253–H2261. [Google Scholar] [CrossRef]
- Sies, H.; Jones, D.P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020, 21, 363–383. [Google Scholar] [CrossRef]
- Franke, J.C.; Plotz, M.; Prokop, A.; Geilen, C.C.; Schmalz, H.G.; Eberle, J. New caspase-independent but ROS-dependent apoptosis pathways are targeted in melanoma cells by an iron-containing cytosine analogue. Biochem. Pharm. 2010, 79, 575–586. [Google Scholar] [CrossRef] [Green Version]
- Zhu, J.Q.; May, S.; Ulrich, C.; Stockfleth, E.; Eberle, J. High ROS Production by Celecoxib and Enhanced Sensitivity for Death Ligand-Induced Apoptosis in Cutaneous SCC Cell Lines. Int. J. Mol. Sci. 2021, 22, 3622. [Google Scholar] [CrossRef]
- Soltan, M.Y.; Sumarni, U.; Assaf, C.; Langer, P.; Reidel, U.; Eberle, J. Key Role of Reactive Oxygen Species (ROS) in Indirubin Derivative-Induced Cell Death in Cutaneous T-Cell Lymphoma Cells. Int. J. Mol. Sci. 2019, 20, 1158. [Google Scholar] [CrossRef] [Green Version]
- Quast, S.A.; Berger, A.; Eberle, J. ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis. Cell Death Dis. 2013, 4, e839. [Google Scholar] [CrossRef]
- Blazevic, T.; Heiss, E.H.; Atanasov, A.G.; Breuss, J.M.; Dirsch, V.M.; Uhrin, P. Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases. Evidence-Based Compl. Alt. 2015, 2015, 654098. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xiao, Z.; Hao, Y.; Liu, B.; Qian, L. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk. Lymphoma 2002, 43, 1763–1768. [Google Scholar] [CrossRef] [PubMed]
- Sun, B.; Wang, J.H.; Liu, L.H.; Mao, L.F.; Peng, L.Z.; Wang, Y.W. Synthesis and activity of novel indirubin derivatives. Chem. Biol. Drug Des. 2021, 97, 565–571. [Google Scholar] [CrossRef] [PubMed]
- Libnow, S.; Methling, K.; Hein, M.; Michalik, D.; Harms, M.; Wende, K.; Flemming, A.; Kockerling, M.; Reinke, H.; Bednarski, P.J.; et al. Synthesis of indirubin-N ‘-glycosides and their anti-proliferative activity against human cancer cell lines. Bioorgan. Med. Chem. 2008, 16, 5570–5583. [Google Scholar] [CrossRef] [PubMed]
- Erben, F.; Kleeblatt, D.; Sonneck, M.; Hein, M.; Feist, H.; Fahrenwaldt, T.; Fischer, C.; Matin, A.; Iqbal, J.; Plotz, M.; et al. Synthesis and antiproliferative activity of selenoindirubins and selenoindirubin-N-glycosides. Org. Biomol. Chem. 2013, 11, 3963–3978. [Google Scholar] [CrossRef]
- Kleeblatt, D.; Becker, M.; Plotz, M.; Schonherr, M.; Villinger, A.; Hein, M.; Eberle, J.; Kunz, M.; Rahman, Q.; Langer, P. Synthesis and bioactivity of N-glycosylated 3-(2-oxo-2-arylethylidene)-indolin-2-ones. Rsc. Adv. 2015, 5, 20769–20782. [Google Scholar] [CrossRef]
- Fecker, L.F.; Stockfleth, E.; Braun, F.K.; Rodust, P.M.; Schwarz, C.; Kohler, A.; Leverkus, M.; Eberle, J. Enhanced Death Ligand-Induced Apoptosis in Cutaneous SCC Cells by Treatment with Diclofenac/Hyaluronic Acid Correlates with Downregulation of c-FLIP. J. Invest. Derm. 2010, 130, 2098–2109. [Google Scholar] [CrossRef] [Green Version]
- Boukamp, P.; Petrussevska, R.T.; Breitkreutz, D.; Hornung, J.; Markham, A.; Fusenig, N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106, 761–771. [Google Scholar] [CrossRef] [Green Version]
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [Green Version]
- Rosenberg, A.R.; Tabacchi, M.; Ngo, K.H.; Wallendorf, M.; Rosman, I.S.; Cornelius, L.A.; Demehri, S. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention. JCI Insight 2019, 4, e125476. [Google Scholar] [CrossRef] [Green Version]
- Marur, S.; Forastiere, A.A. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin. Proc. 2016, 91, 386–396. [Google Scholar] [CrossRef] [Green Version]
- Dothager, R.S.; Putt, K.S.; Allen, B.J.; Leslie, B.J.; Nesterenko, V.; Hergenrother, P.J. Synthesis and identification of small molecules that potently induce apoptosis in melanoma cells through G1 cell cycle arrest. J. Am. Chem. Soc. 2005, 127, 8686–8696. [Google Scholar] [CrossRef]
- Schafer, M.; Semmler, M.L.; Bernhardt, T.; Fischer, T.; Kakkassery, V.; Ramer, R.; Hein, M.; Bekeschus, S.; Langer, P.; Hinz, B.; et al. Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins. Cancers 2021, 13, 1770. [Google Scholar] [CrossRef]
- You, W.C.; Hsieh, C.C.; Huang, J.T. Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis. J. Altern. Complement. Med. 2009, 15, 771–778. [Google Scholar] [CrossRef]
- Ahn, M.Y.; Kim, T.H.; Kwon, S.M.; Yoon, H.E.; Kim, H.S.; Kim, J.I.; Kim, Y.C.; Kang, K.W.; Ahn, S.G.; Yoon, J.H. 5-Nitro-5′-hydroxy-indirubin-3′-oxime (AGM130), an indirubin-3′-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo. Eur. J. Pharm. Sci. 2015, 79, 122–131. [Google Scholar] [CrossRef]
- Zhang, Y.M.; Du, Z.X.; Zhuang, Z.R.; Wang, Y.J.; Wang, F.; Liu, S.; Wang, H.; Feng, H.R.; Li, H.Y.; Wang, L.Y.; et al. E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling. J. Neuro Oncol. 2015, 125, 265–275. [Google Scholar] [CrossRef]
- Braig, S.; Bischoff, F.; Abhari, B.A.; Meijer, L.; Fulda, S.; Skaltsounis, L.; Vollmar, A.M. The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer. Biochem. Pharm. 2014, 91, 157–167. [Google Scholar] [CrossRef]
- Ndolo, K.M.; Park, K.R.; Lee, H.J.; Bin Yoon, K.; Kim, Y.C.; Han, S.Y. Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells. Immune Netw. 2017, 17, 110–115. [Google Scholar] [CrossRef] [Green Version]
- Lee, H.J.; Jeong, P.; Moon, Y.; Choi, J.; Heo, J.D.; Kim, Y.C.; Han, S.Y. Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. Pharm. Base 2021, 14, 38. [Google Scholar] [CrossRef]
- Tanaka, T.; Saito, H.; Miyairi, S.; Kobayashi, S. 7-Hydorxyindirubin is capable of specifically inhibiting anticancer drug-induced YB-1 nuclear translocation without showing cytotoxicity in HepG2 hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2021, 544, 15–21. [Google Scholar] [CrossRef]
- Zhivkova, V.; Kiecker, F.; Langer, P.; Eberle, J. Crucial role of reactive oxygen species (ROS) for the proapoptotic effects of indirubin derivative DKP-073 in melanoma cells. Mol. Carcinog. 2019, 58, 258–269. [Google Scholar] [CrossRef]
- Kunz, M.; Driller, K.M.; Hein, M.; Libnow, S.; Hohensee, I.; Ramer, R.; Hinz, B.; Berger, A.; Eberle, J.; Langer, P. Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis. ChemMedChem 2010, 5, 534–539. [Google Scholar] [CrossRef]
- Deveraux, Q.L.; Takahashi, R.; Salvesen, G.S.; Reed, J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388, 300–304. [Google Scholar] [CrossRef]
- Nam, S.; Buettner, R.; Turkson, J.; Kim, D.; Cheng, J.Q.; Muehlbeyer, S.; Hippe, F.; Vatter, S.; Merz, K.H.; Eisenbrand, G.; et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc. Natl. Acad. Sci. USA 2005, 102, 5998–6003. [Google Scholar] [CrossRef] [Green Version]
- Liu, L.; Gaboriaud, N.; Vougogianopoulou, K.; Tian, Y.; Wu, J.; Wen, W.; Skaltsounis, L.; Jove, R. MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biol. 2014, 15, 178–184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chipuk, J.E.; Green, D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 2008, 18, 157–164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Banerjee, K.; Resat, H. Constitutive activation of STAT3 in breast cancer cells: A review. Int. J. Cancer 2016, 138, 2570–2578. [Google Scholar] [CrossRef] [PubMed]
- Sumarni, U.; Reidel, U.; Eberle, J. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKC delta Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP. Cells 2021, 10, 987. [Google Scholar] [CrossRef]
- Kurbanov, B.M.; Geilen, C.C.; Fecker, L.F.; Orfanos, C.E.; Eberle, J. Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Invest. Derm. 2005, 125, 1010–1019. [Google Scholar] [CrossRef] [Green Version]
- Shi, J.; Shen, H.M. Critical role of Bid and Bax in indirubin-3′-monoxime-induced apoptosis in human cancer cells. Biochem. Pharm. 2008, 75, 1729–1742. [Google Scholar] [CrossRef]
- Berger, A.; Quast, S.A.; Plotz, M.; Hein, M.; Kunz, M.; Langer, P.; Eberle, J. Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative-Enhancement of both extrinsic and intrinsic apoptosis pathways. Biochem. Pharm. 2011, 81, 71–81. [Google Scholar] [CrossRef] [Green Version]
- Kameswaran, T.R.; Ramanibai, R. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells. Biomed. Pharm. 2009, 63, 146–154. [Google Scholar] [CrossRef]
- Liu, P.; Yang, W.T.; Shi, L.; Zhang, H.Y.; Xu, Y.; Wang, P.R.; Zhang, G.L.; Chen, W.R.; Zhang, B.B.; Wang, X.L. Concurrent photothermal therapy and photodynamic therapy for cutaneous squamous cell carcinoma by gold nanoclusters under a single NIR laser irradiation. J. Mater. Chem. B 2019, 7, 6924–6933. [Google Scholar] [CrossRef]
- Austin, E.; Koo, E.; Jagdeo, J. Thermal photodynamic therapy increases apoptosis and reactive oxygen species generation in cutaneous and mucosal squamous cell carcinoma cells. Sci. Rep. 2018, 8, 12599. [Google Scholar]
- Niu, T.H.; Tian, Y.; Wang, G.Y.; Guo, G.J.; Tong, Y.; Shi, Y. Inhibition of ROS-NF-kappa B-dependent autophagy enhances Hypocrellin A united LED red light-induced apoptosis in squamous carcinoma A431 cells. Cell Signal. 2020, 69. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zhu, J.; Langer, P.; Ulrich, C.; Eberle, J. Crucial Role of Reactive Oxygen Species (ROS) for the Proapoptotic Effects of Indirubin Derivatives in Cutaneous SCC Cells. Antioxidants 2021, 10, 1514. https://doi.org/10.3390/antiox10101514
Zhu J, Langer P, Ulrich C, Eberle J. Crucial Role of Reactive Oxygen Species (ROS) for the Proapoptotic Effects of Indirubin Derivatives in Cutaneous SCC Cells. Antioxidants. 2021; 10(10):1514. https://doi.org/10.3390/antiox10101514
Chicago/Turabian StyleZhu, Jiaqi, Peter Langer, Claas Ulrich, and Jürgen Eberle. 2021. "Crucial Role of Reactive Oxygen Species (ROS) for the Proapoptotic Effects of Indirubin Derivatives in Cutaneous SCC Cells" Antioxidants 10, no. 10: 1514. https://doi.org/10.3390/antiox10101514